These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6523843)

  • 1. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N
    Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N
    Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N
    Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N; Dimitrova V
    Vutr Boles; 1987; 26(1):21-7. PubMed ID: 3590722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities of combined treatment of diffuse collagenous glomerulonephritis].
    Belovezhdov N; Tsekova D; Dzherasi R; Gruev I; Kiperova B
    Vutr Boles; 1982; 21(5):25-34. PubMed ID: 7164403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled therapeutic trial in IgA glomerulonephritis].
    Belovezhdov N; Robeva R
    Vutr Boles; 1982; 21(3):49-53. PubMed ID: 7051564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of idiopathic membranous nephropathy.
    Ehrenreich T; Porush JG; Churg J; Garfinkel L; Glabman S; Goldstein MH; Grishman E; Yunis SL
    N Engl J Med; 1976 Sep; 295(14):741-6. PubMed ID: 958260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
    Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
    Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic glomerulonephritis with high doses of intravenous immunoglobulin].
    Belovezhdov N; Monova D; Altŭnkova I; Robeva R
    Vutr Boles; 1990; 29(1):59-68. PubMed ID: 2396419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of membranous glomerulonephritis].
    Stavskaia VV; Riabov SI
    Ter Arkh; 1985; 57(6):74-8. PubMed ID: 4071419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
    [No Abstract]   [Full Text] [Related]  

  • 19. Membranous nephropathy.
    Churg J; Ehrenreich T
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():443-8. PubMed ID: 4536436
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.